Hepatitis C virus viral kinetics during a-2a or a-2b pegylated interferon plus ribavirin therapy in liver transplant recipients with different immunosuppression regimes.

Autores de IIS La Fe

• 

  Marina Berenguer Haym

  Autor

• Cecilia Ortiz Canto

  Autor

• Victoria Aguilera Sancho-Tello

  Autor

• Ángel Rubín Suárez

  Autor

• Martín Prieto Castillo

  Autor

• Francisco Xavier López Labrador

  Autor

Participantes ajenos a IIS La Fe

• Abellán JJ

Grupos

• Hepatología, Cirugia Hepatobiliopancreática y Trasplantes

Abstract

Predictors of sustained virological response (SVR) to antiviral therapy post-liver transplantation (LT) for chronic hepatitis C are needed. In non-transplanted patients, viral kinetics can predict SVR.